By taking a strategic and evidence-based approach, companies can leverage the insights gained from stability studies to establish robust labeling.
Shailesh Vengurlekar
Advertisement
Shailesh Vengurlekar is senior vice-president, Quality and Regulatory Affairs, at LGM Pharma.
Articles by Shailesh Vengurlekar
Advertisement
Latest Updated Articles
Establishing a Framework for Reliable Pharma LabelingDecember 2nd 2023
Advertisement
Advertisement